Jazz Pharmaceuticals plc — Director's Dealing 2020

Aug 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-08-05

Reporting Person: Patil Neena M (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-05	Ordinary Shares	F	987	$122.24	Disposed	19489	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 76 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2020.